Decoy Therapeutics (DCOY) Change in Receivables (2016 - 2020)
Decoy Therapeutics (DCOY) posted quarterly Change in Receivables of -$1.8 million for Q3 2020, down 265760.72% year-over-year from N/an in Q4 2019, and down 247.54% quarter-over-quarter from $1.2 million in Q2 2020.
Decoy Therapeutics (DCOY) Change in Receivables (2016 - 2020) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Change in Receivables for 5 consecutive years, with -$1.8 million the latest figure, recorded in Q3 2020.
- In Q3 2020, Change in Receivables fell 265760.72% year-over-year to -$1.8 million; the TTM figure through Jun 2020 stood at $1.8 million (up 996702.72% YoY), while the FY2019 annual figure was -$690.0, changed N/A from the prior year.
- Change in Receivables retreated to -$1.8 million in Q3 2020 per DCOY's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $1.2 million in Q2 2020 and bottomed at -$1.8 million in Q3 2020.
- Historically, Change in Receivables has averaged $692.5 across 5 years, with a median of $2548.5 in 2017.
- Annual changes were most pronounced in 2017 — Change in Receivables surged 35.17% — and 2020, when it plunged 265760.72%.
- Decoy Therapeutics' Change in Receivables stood at -$9606.0 in 2016, then tumbled by 157.64% to -$24749.0 in 2017, then surged by 99.26% to -$184.0 in 2018, then slumped by 275.0% to -$690.0 in 2019, then slumped by 265760.72% to -$1.8 million in 2020.
- Business Quant data shows DCOY's Change in Receivables at -$1.8 million in Q3 2020, $1.2 million in Q2 2020, and $591129.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -1.83 Mn |
| Sep 30, 2020 | -1.83 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Mar 31, 2020 | 591,129.00 |
| Mar 31, 2020 | 591,129.00 |
| Sep 30, 2019 | -690.00 |
| Sep 30, 2019 | -690.00 |
| Sep 30, 2018 | -184.00 |
| Sep 30, 2018 | -184.00 |
| Jun 30, 2018 | 4,698.00 |
| Jun 30, 2018 | 4,698.00 |
| Mar 31, 2018 | -4,514.00 |
| Mar 31, 2018 | -4,514.00 |
| Dec 31, 2017 | -24,749.00 |
| Dec 31, 2017 | -24,749.00 |
| Sep 30, 2017 | 399.00 |
| Sep 30, 2017 | 399.00 |
| Jun 30, 2017 | 15,673.00 |
| Jun 30, 2017 | 15,673.00 |